EC Number   |
Disease |
PubMed ID  |
Title of Publication |
Category |
Confidence Level |
|---|
   4.1.1.53 | Movement Disorders |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application
unassigned |
1
0 |
| 4.1.1.53 | Multiple System Atrophy |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application
unassigned |
1
0 |
| 4.1.1.53 | Paralysis |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application
unassigned |
1
0 |
| 4.1.1.53 | Parkinson Disease |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application
unassigned |
1
0 |
| 4.1.1.53 | Supranuclear Palsy, Progressive |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application
unassigned |
1
0 |
| 4.1.1.53 | Tremor |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application
unassigned |
1
0 |
| 4.1.1.53 | phenylalanine decarboxylase deficiency |
34244047 |
Corrigendum to "Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook" [Mol Genet Metab. 2019 May;127(1):12-22]. |
unassigned |
0 |
| 4.1.1.53 | Neuroendocrine Tumors |
34495420 |
The effects of molar activity on [18F]FDOPA uptake in patients with neuroendocrine tumors. |
unassigned |
0 |
